Feasibility and Reliability of the Melbourne Assessment-2 (MA-2) for Telehealth
Launched by OHIO STATE UNIVERSITY · Feb 4, 2025
Trial Information
Current as of May 18, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how well a play-based test can assess arm and hand movements in children with hemiplegic cerebral palsy when done through telehealth, or online video sessions. The researchers want to find out if this method is just as effective as in-person assessments. They will also compare how engaged children and their families are during both types of assessments and gather caregivers' opinions on their experiences.
To participate, children must be between 2 and 10 years old, have hemiplegic cerebral palsy, and be able to attend one visit in person and one online session. The trial involves two visits where children will play with toys while their movements are recorded and assessed using specific tools. This is a great opportunity for families living within 60 miles of the research lab, as they can help improve ways to assess and support children with this condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ages 2-10 years old
- • hemiplegic cerebral palsy
- • able to attend an in-person visit in the research lab OR live within 60 miles of the research lab
- • able to attend a telehealth session with personal device
- Exclusion Criteria:
- • child or caregiver does not speak English
- • unable to attend one in person visit and one telehealth visit within 1 month
About Ohio State University
The Ohio State University (OSU) is a leading research institution dedicated to advancing health and science through innovative clinical trials. With a commitment to improving patient care and outcomes, OSU leverages its extensive resources, interdisciplinary collaboration, and expertise in diverse medical fields. The university fosters an environment of rigorous scientific inquiry, ensuring that clinical trials are conducted with the highest ethical standards and adherence to regulatory guidelines. Through its Clinical Trials Office, OSU aims to translate groundbreaking research into practical applications, benefiting both local and global communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Columbus, Ohio, United States
Patients applied
Trial Officials
Jill Heathcock, PhD
Principal Investigator
Ohio State University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported